Merit Medical Systems MMSI Payments For Derivative Instrument Financing Activities

Payments For Derivative Instrument Financing Activities at other companies

ITG

Integer HoldingsITGR

$0-100%

Revenue$381.9M+7.5%

Gross profit$184.8M+7.4%

Operating income$44.2M+7.6%

Net income$41.0M+36.0%

EPS (diluted)$0.68+38.8%

Cash & equivalents$488.1M+23.4%

Total debt$821.6M+0.5%

Total equity$1.6B+13.9%

Total assets$2.7B+10.2%

Operating cash flow$40.7M+0.3%

CapEx$16.0M-24.0%

Free cash flow$24.7M+26.5%

Market cap$4.01B-34.1%

Gross margin48.7%+0.9pp

Operating margin12.2%+0.6pp

Net margin9%+0.2pp

FCF margin14.3%+1.3pp

Return on equity9.1%0.0pp

Debt / equity0.5×-0.1×

Current ratio5.1×+0.2×

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForDerivativeInstrumentFinancingActivities.

The official record: Merit Medical Systems’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Merit Medical Systems's payments for derivative instrument financing activities?: Merit Medical Systems (MMSI) reported payments for derivative instrument financing activities of $16.63M in Q4 2023.
What does payments for derivative instrument financing activities mean?: Captures cash outflows related to the settlement of derivative instruments used for financing purposes, such as interest rate swaps or hedging debt-related risks. These payments reflect the cost of managing financial market volatility and interest rate exposure. Monitoring these payments helps assess the company's effectiveness in hedging its financial liabilities.